Market Place
Sourcing Support
Biocad`s BCD-021 Bevacizumab Biosimilar Demonstrates Equivalence in NSCLC
19 Sep 2021 //
FIRSTWORDPHARMA
Biocad discussing potential COVID-19 vaccine production in China
27 Jul 2020 //
REUTERS
Russia registers new drug to contain complications caused by COVID-19
07 Jun 2020 //
CGTN
BIOCAD rituximab biosimilar to receive market authorisation in India
04 Jul 2017 //
MANUFACTURING
BIOCAD registered the first rituximab biosimilar in Bolivia and Honduras
05 Jun 2017 //
BUSINESSWIRE
Roche Wants Russian Co., Counsel Penalized For Drug Suit
10 Mar 2017 //
LAW
BIOCAD develops rheumatoid arthritis drug, BCD-121
11 Jul 2016 //
PHARMABIZ
Biocad ships Herceptin biosimilar to Sri Lanka
30 Mar 2016 //
BIOPHARMA REPORTER
BIOCAD Score Victory in mAb biosimilar With Market Authorization for Bevacizumab
09 Dec 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.